|
US2019060359A1
|
|
Treatment of neurodegenerative disease with sodium chlorite
|
|
EP3370738A2
|
|
Treatment of neurodegenerative disease with sodium chlorite
|
|
AU2015255176A1
|
|
Chlorite formulations, and methods of preparation and use thereof
|
|
AU2015258892A1
|
|
Methods and compositions for treatment of macrophage-related disorders
|
|
AU2014265137A1
|
|
Compositions and methods for the treatment of altered alpha-synuclein function
|
|
AU2013234421A1
|
|
Chlorite formulations, and methods of preparation and use thereof
|
|
AU2010281524A1
|
|
Treatment of macrophage-related disorders
|
|
BRPI0920498A2
|
|
method of treating a condition in a subject
|
|
BRPI0822349A2
|
|
compositions and methods for treating lysosomal diseases
|
|
AU2006331497A1
|
|
Chlorite formulations, and methods of preparation and use thereof
|
